Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross-sectional study
dc.authorid | Teoman Akçay / 0000-0002-8252-7089 | |
dc.authorscopusid | Teoman Akçay / 23968688000 | |
dc.authorwosid | Teoman Akçay / AFG-8460-2022 | |
dc.contributor.author | Hatun, S. | |
dc.contributor.author | Mutlu, G. Yeşiltepe | |
dc.contributor.author | Cinaz, P. | |
dc.contributor.author | Turan, S. | |
dc.contributor.author | Ekberzade, A. | |
dc.contributor.author | Bereket, A. | |
dc.contributor.author | Erbaş, M. Y. | |
dc.contributor.author | Önal, H. | |
dc.contributor.author | Bolu, S. | |
dc.contributor.author | Arslanoğlu, I. | |
dc.contributor.author | Döğer, E. | |
dc.contributor.author | Yılmaz, A. A. | |
dc.contributor.author | Uçaktürk, A. | |
dc.contributor.author | Karabulut, G. S. | |
dc.contributor.author | Tuhan, H. U. | |
dc.contributor.author | Demir, K. | |
dc.contributor.author | Erdeve, S. S. | |
dc.contributor.author | Aycan, Z. | |
dc.contributor.author | Nalbantoğlu, O. | |
dc.contributor.author | Kara, C. | |
dc.contributor.author | Güngör, N. | |
dc.contributor.author | Darendeliler, Feyza | |
dc.contributor.author | Bundak, Rüveyde | |
dc.contributor.author | Anık, Ahmet | |
dc.contributor.author | Uçar, Ahmet | |
dc.contributor.author | Çayır, Atilla | |
dc.contributor.author | Ergür, Ayça Törel | |
dc.contributor.author | Özcabi, Bahar | |
dc.contributor.author | Haliloğlu, Belma | |
dc.contributor.author | Özkan, Behzat | |
dc.contributor.author | Eklioğlu, Beray Selver | |
dc.contributor.author | Kirel, Birgül | |
dc.contributor.author | Bezen, Digdem | |
dc.contributor.author | Vurallı, Doğus | |
dc.contributor.author | Ünal, Edip) | |
dc.contributor.author | Sağsak, Elif | |
dc.contributor.author | Bugrul, Fuat | |
dc.contributor.author | Çatlı, Gönül | |
dc.contributor.author | Korkmaz, Hüseyin Anıl | |
dc.contributor.author | Özbek, Mehmet Nuri | |
dc.contributor.author | Tayfun, Meltem | |
dc.contributor.author | Genens, Mikayir | |
dc.contributor.author | Büyük, Muammer | |
dc.contributor.author | Hatipoğllu, Nihal | |
dc.contributor.author | Abalı, Saygın | |
dc.contributor.author | Kiremitçi, Seniha | |
dc.contributor.author | Curek, Yusuf | |
dc.contributor.author | Siklar, Zeynep | |
dc.contributor.author | Akçay, Teoman | |
dc.date.accessioned | 2020-08-30T20:06:33Z | |
dc.date.available | 2020-08-30T20:06:33Z | |
dc.date.issued | 2019 | |
dc.department | İstinye Üniversitesi, Hastane | en_US |
dc.description.abstract | Aims To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey. Methods A standard questionnaire regarding clinical and laboratory characteristics at onset was uploaded to an online national database system. Data for 367 children (aged 6-18 years) newly diagnosed with Type 2 diabetes at 37 different paediatric endocrinology centres were analysed. Results After exclusion of the children with a BMI Z-score < 1 SD, those with genetic syndromes associated with Type 2 diabetes, and those whose C-peptide and/or insulin levels were not available, 227 cases were included in the study. Mean age was 13.8 +/- 2.2 (range 6.5-17.8) years, with female preponderance (68%). Family history of Type 2 diabetes was positive in 86% of the children. The mean BMI was 31.3 +/- 6.5 kg/m(2) (range 18.7-61) and BMI Z-score was 2.4 +/- 0.8 (range 1-5). More than half (57%) of the children were identified by an opportunistic diabetes screening due to existing risk markers without typical symptoms of diabetes. Only 13% (n = 29) were treated solely by lifestyle modification, while 40.5% (n = 92) were treated with metformin, 13% (n = 30) were treated with insulin, and 33.5% (n = 76) were treated with a combination of insulin and metformin initially. Mean HbA(1C) levels of the insulin and combination of insulin and metformin groups were 98 (11.1%) and 102 mmol/mol (11.5%), respectively, and also were significantly higher than the lifestyle modification only and metformin groups mean HbA(1C) levels (70(8.6%) and 67 mmol/mol (8.3%), respectively). Conclusions An opportunistic screening of children who are at high risk of Type 2 diabetes is essential, as our data showed that > 50% of the children were asymptomatic at diagnosis. The other important result of our study was the high rate of exclusion from the initial registration (38%), suggesting that accurate diagnosis of Type 2 diabetes in youth is still problematic, even for paediatric endocrinologists. | en_US |
dc.identifier.citation | Hatun, S., Yesiltepe Mutlu, G., Cinaz, P., Turan, S. U. L. T. A. N., Ekberzade, A., Bereket, A. B. D. U. L. L. A. H., ... & Arslanoglu, I. (2019). Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study. Diabetic Medicine, 36(10), 1243-1250. | en_US |
dc.identifier.doi | 10.1111/dme.14038 | en_US |
dc.identifier.endpage | 1250 | en_US |
dc.identifier.issn | 0742-3071 | en_US |
dc.identifier.issn | 1464-5491 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | 31099079 | en_US |
dc.identifier.scopus | 2-s2.0-85068536497 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 1243 | en_US |
dc.identifier.uri | https://doi.org/10.1111/dme.14038 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/553 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000487006600007 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Akçay, Teoman | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Diabetic Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross-sectional study | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- H51.pdf
- Boyut:
- 157.7 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/ Full Text